arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ALUMIS INC.

ALMS
$27.53 ▼ -0.25 (-0.90%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
4 Visible periods
21 Metrics
Peer-ranked Benchmarks
Price Chart
31
Health
Poor
Bearish
auto_awesome

Analytical Summary

ALUMIS INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.3B
Dividend Yield
Revenue Growth
Op. Margin
ROIC -145.5%
FCF / Share $-4.35
Trailing P/E
Price / Book 7.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

4-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-243.32M
↑ +17.3%
FCF / Share Free cash flow per share
$-4.35
↑ +52.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
11
Cash Quality
80

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 14 quarters